GNH USA

Europe — EMA

Melkart

GNH USA supplies Melkart (Vildagliptin), a DPP‑4 inhibitor for type 2 diabetes mellitus. Request a quote for GMP‑certified global supply with fast delivery.

Vildagliptin

Request sourcing

1
Pack/s

What is Vildagliptin?

Vildagliptin, the active ingredient in Melkart, is a DPP-4 inhibitor presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients.

GNH USA supplies Melkart as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Vildagliptin used for?

Melkart is a DPP‑4 inhibitor indicated for the management of type 2 diabetes mellitus.

- Type 2 diabetes mellitus (monotherapy): improves glycaemic control when used alone with diet and exercise. - Type 2 diabetes mellitus (combination therapy): enhances glucose lowering when added to metformin or sulfonylureas. - Type 2 diabetes mellitus (elderly patients): provides effective HbA1c reduction with a low risk of hypoglycaemia when appropriately monitored.

What are the side effects of Vildagliptin?

Adverse reactions may occur with any medication.

Common Side Effects: - Nasopharyngitis: mild upper respiratory tract infection symptoms. - Headache: transient mild to moderate headache. - Dizziness: occasional sensation of light‑headedness. - Upper respiratory tract infection: cough, sore throat, or congestion. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Pancreatitis: severe abdominal pain requiring immediate medical attention. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Bullous pemphigoid: rare skin blistering disorder. - Hypersensitivity: fever, eosinophilia, or organ involvement.

What precautions apply to Vildagliptin?

Use melkart with appropriate clinical monitoring and consider patient‑specific factors.

- Renal impairment: assess kidney function and adjust dose in moderate to severe impairment. - Hepatic disease: monitor liver function tests regularly. - Hypoglycaemia risk: increased when combined with insulin or sulfonylureas; educate patients on symptoms. - Pancreatitis: discontinue if persistent severe abdominal pain occurs. - Pregnancy and lactation: only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

What does Vildagliptin interact with?

Vildagliptin may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Insulin: concurrent use can cause severe hypoglycaemia. - Sulfonylureas (e.g., glimepiride): heightened risk of low blood glucose. - Strong CYP3A4 inhibitors: may increase exposure, though effect is limited.

Moderate Interactions (Monitor Closely): - Rifampin: may reduce vildagliptin plasma levels. - Diuretics: monitor electrolytes and blood pressure. - Warfarin: observe INR for potential changes.

Frequently asked questions

What is Melkart used for?+
Melkart contains vildagliptin, a DPP‑4 inhibitor prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus, either as a stand‑alone therapy or in combination with other antidiabetic agents such as metformin or sulfonylureas.
How does vildagliptin work?+
Vildagliptin blocks the DPP‑4 enzyme, which normally degrades the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances glucose‑dependent insulin secretion and reduces glucagon release, leading to lower blood glucose levels after meals and throughout the day.
What is the usual dose of Melkart?+
The dosage of Melkart is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and concomitant therapies. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.
Is Melkart safe during pregnancy or breastfeeding?+
Safety data for vildagliptin in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.
How do I order Melkart from GNH USA?+
To request Melkart, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Melkart compare with other DPP‑4 inhibitors?+
Melkart (vildagliptin) shares the same mechanism of action as other DPP‑4 inhibitors such as sitagliptin or linagliptin. Clinical studies show comparable efficacy in lowering HbA1c, while differences may exist in dosing frequency, renal adjustment requirements, and individual safety profiles, which clinicians consider when selecting therapy.
How should Melkart be stored and handled?+
Melkart tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.
How is Melkart administered?+
Melkart is taken orally, usually once daily with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise instructed.
What are the most serious risks associated with Melkart?+
The most serious adverse events linked to vildagliptin include acute pancreatitis, severe allergic reactions such as anaphylaxis, and rare skin disorders like bullous pemphigoid. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, or signs of an allergic response.
Who should not use Melkart?+
Melkart is contraindicated in patients with a known hypersensitivity to vildagliptin or any of the tablet’s excipients. It should be used with caution, or avoided, in individuals with severe renal impairment, active pancreatitis, or those who are pregnant or breastfeeding without a clear medical justification.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Vildagliptin
Route
Oral Use
Manufacturer
G.L. Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU